Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126118191 | 12611819 | 1 | I | 20160328 | 20160729 | 20160801 | 20160801 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50077BP | BOEHRINGER INGELHEIM | 76.41 | YR | F | Y | 0.00000 | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126118191 | 12611819 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | ||||||
| 126118191 | 12611819 | 2 | C | Klorcon | 2 | Oral | 20 MEQ | 0 | 20 | MEQ | TABLET | QD | |||||||
| 126118191 | 12611819 | 3 | C | BUMEX | BUMETANIDE | 1 | Oral | 2 MG | 0 | 1 | MG | TABLET | BID | ||||||
| 126118191 | 12611819 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG | 0 | 12.5 | MG | TABLET | BID | ||||||
| 126118191 | 12611819 | 5 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG | 0 | 300 | MG | TABLET | BID | ||||||
| 126118191 | 12611819 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG | 0 | 300 | MG | TABLET | QD | ||||||
| 126118191 | 12611819 | 7 | C | ELIQUIS | APIXABAN | 1 | Oral | 5 MG | 0 | 2.5 | MG | TABLET | BID | ||||||
| 126118191 | 12611819 | 8 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 126118191 | 12611819 | 9 | C | Dictoxacillin | 2 | Oral | 1000 MG | 0 | 500 | MG | CAPSULE | BID | |||||||
| 126118191 | 12611819 | 10 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
| 126118191 | 12611819 | 11 | C | ISOSORBIDE. | ISOSORBIDE | 1 | Oral | 60 MG | 0 | 30 | MG | TABLET | BID | ||||||
| 126118191 | 12611819 | 12 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG | 0 | 40 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126118191 | 12611819 | 1 | Product used for unknown indication |
| 126118191 | 12611819 | 2 | Blood potassium decreased |
| 126118191 | 12611819 | 3 | Cardiac failure congestive |
| 126118191 | 12611819 | 4 | Cardiac failure congestive |
| 126118191 | 12611819 | 5 | Pain |
| 126118191 | 12611819 | 6 | Gout |
| 126118191 | 12611819 | 7 | Product used for unknown indication |
| 126118191 | 12611819 | 8 | Blood cholesterol increased |
| 126118191 | 12611819 | 9 | Localised infection |
| 126118191 | 12611819 | 10 | Cardiac failure congestive |
| 126118191 | 12611819 | 11 | Cardiac failure congestive |
| 126118191 | 12611819 | 12 | Abdominal discomfort |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126118191 | 12611819 | LT |
| 126118191 | 12611819 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126118191 | 12611819 | Cardiac arrest | |
| 126118191 | 12611819 | Cardiac failure congestive | |
| 126118191 | 12611819 | Fall | |
| 126118191 | 12611819 | Rib fracture | |
| 126118191 | 12611819 | Spinal fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126118191 | 12611819 | 1 | 2012 | 0 |